| 1 |
Zhu M, Wang X, Wang K, Zhao Z, Dang Y, Ji G, Li F, Zhou W. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites. Front Cell Infect Microbiol 2023;13:1066053. [PMID: 36779187 DOI: 10.3389/fcimb.2023.1066053] [Reference Citation Analysis]
|
| 2 |
Xu Z, Wu FW, Niu X, Lu XP, Li YR, Zhang ST, Ou JZ, Wang XM. Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease. Pharm Biol 2022;60:1819-38. [PMID: 36124995 DOI: 10.1080/13880209.2022.2106250] [Reference Citation Analysis]
|
| 3 |
Yin G, Liang H, Sun W, Zhang S, Feng Y, Liang P, Chen S, Liu X, Pan W, Zhang F. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. Front Pharmacol 2022;13:1016745. [PMID: 36506575 DOI: 10.3389/fphar.2022.1016745] [Reference Citation Analysis]
|
| 4 |
Zhu L, Wu X, Liao R. Mechanism and regulation of mitophagy in nonalcoholic fatty liver disease (NAFLD): A mini-review. Life Sci 2022;312:121162. [PMID: 36372213 DOI: 10.1016/j.lfs.2022.121162] [Reference Citation Analysis]
|
| 5 |
Yang R, Yang H, Jiang D, Xu L, Feng L, Xing Y. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation. PeerJ 2022;10:e14171. [PMID: 36389420 DOI: 10.7717/peerj.14171] [Reference Citation Analysis]
|
| 6 |
Wu Q, Chen Z, Ding Y, Tang Y, Cheng Y. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis. Front Nutr 2022;9:1033129. [DOI: 10.3389/fnut.2022.1033129] [Reference Citation Analysis]
|
| 7 |
Zhang Y, Liu T, Zhang L, Pu Z, Yan Z, Hua H. Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Front Pharmacol 2022;13:1039611. [DOI: 10.3389/fphar.2022.1039611] [Reference Citation Analysis]
|
| 8 |
Chen X, Liu M, Tang J, Wang N, Feng Y, Ma H. Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis. IJMS 2022;23:11710. [DOI: 10.3390/ijms231911710] [Reference Citation Analysis]
|
| 9 |
Xue H, Wang Y, Xiang H, Song Q, Zhang G, Wang J, Ge S. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-17. [DOI: 10.1155/2022/5440347] [Reference Citation Analysis]
|
| 10 |
Zhou Z, Zhang J, You L, Wang T, Wang K, Wang L, Kong X, Gao Y, Sun X. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine. Front Endocrinol 2022;13:1000727. [DOI: 10.3389/fendo.2022.1000727] [Reference Citation Analysis]
|
| 11 |
Shao M, Lu Y, Xiang H, Wang J, Ji G, Wu T. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine. Front Pharmacol 2022;13:971561. [DOI: 10.3389/fphar.2022.971561] [Reference Citation Analysis]
|
| 12 |
Jiang H, Mao T, Liu Y, Tan X, Sun Z, Cheng Y, Han X, Zhang Y, Wang J, Shi L, Guo Y, Li J, Han H. Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification. Front Pharmacol 2022;13:908128. [PMID: 35721171 DOI: 10.3389/fphar.2022.908128] [Reference Citation Analysis]
|
| 13 |
Cao Y, Shi J, Song L, Xu J, Lu H, Sun J, Hou J, Chen J, Wu W, Gong L. Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction. Front Pharmacol 2022;13:858795. [DOI: 10.3389/fphar.2022.858795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Liu J, Zhang T, Zhu J, Ruan S, Li R, Guo B, Lin L. Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy. Chin Med 2021;16:115. [PMID: 34777572 DOI: 10.1186/s13020-021-00528-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
